HODHBt

CAS No. 28230-32-2

HODHBt( —— )

Catalog No. M22874 CAS No. 28230-32-2

HODHBt is a STAT5-SUMO protein-protein interaction inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 35 In Stock
200MG 50 In Stock
500MG 82 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HODHBt
  • Note
    Research use only, not for human use.
  • Brief Description
    HODHBt is a STAT5-SUMO protein-protein interaction inhibitor.
  • Description
    HODHBt is a STAT5-SUMO protein-protein interaction inhibitor.
  • In Vitro
    HODHBt (100 μM; 24 h, and 48 h respectively) increases IL-15-mediated STAT phosphorylation in NK cells and enhances the cytotoxic profile of NK cells.HODHBt (100 μM; 24 h) enhances IL-15-mediated (100 ng/mL) cytotoxicity of NK cells against HIV-infected cells (K562 cells).HODHBt (100 μM; 24 h) enhances IL-15-mediated (100 ng/mL, 6 h) cytotoxicity of NK cells against cancer cell lines (A2780 and U877; OCILy1 and OCILy10).HODHBt (100 μM; 7 d) results in enhanced memory response upon recall in generation of human CIML NK cells in vitro.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    JAK/STAT Signaling
  • Target
    STAT
  • Recptor
    STAT5
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28230-32-2
  • Formula Weight
    163.14
  • Molecular Formula
    C7H5N3O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:Soluble
  • SMILES
    C1=CC=C2C(=C1)C(=O)N(N=N2)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bosque et al (2017) Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation. Cell Rep. 18 1324 PMID: 28147284
molnova catalog
related products
  • InS3-54A18

    InS3-54A18 is an active analog of inS3-54 targeting the DBD of STAT3 with IC50 of 8.8 uM in STAT3-dependent luciferase reporter assay.

  • Nirsevimab

    Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region, efficiently targeting RSV-B with a Kd value of 1.5 nM, and can be used to prevent RSV infection.

  • STAT5 inhibitor 17f

    A novel potent, selective inhibitor of phosphorylation and transcriptional activity of STAT5, but not STAT3, AKT, or Erk1/2 phosphorylation.